Search results for " Depressive disorder"

showing 10 items of 133 documents

Association between muscular strength and cognition in people with major depression or bipolar disorder and healthy controls

2018

Importance Objective physical fitness measures, such as handgrip strength, are associated with physical, mental, and cognitive outcomes in the general population. Although people with mental illness experience reduced physical fitness and cognitive impairment, the association between muscular strength and cognition has not been examined to date. Objective To determine associations between maximal handgrip strength and cognitive performance in people with major depression or bipolar disorder and in healthy controls. Design, Setting, and Participants In a multicenter, population-based study conducted between February 13, 2005, and October 1, 2010, in the United Kingdom, cross-sectional analys…

AdultMaleBipolar DisorderPhysical fitnessMuscle Strength DynamometerPhysical strength03 medical and health sciences0302 clinical medicineCognitionHand strengthmedicineHumansCognitive Dysfunction030212 general & internal medicineBipolar disorderMuscle StrengthAgedOriginal Investigationhandgrip strengthDepressive Disorder MajorHand Strengthbusiness.industryMiddle AgedMental illnessmedicine.diseaseHealthy VolunteersPsychiatry and Mental healthCross-Sectional StudiesSchizophreniaPhysical FitnessCase-Control StudiesdepressionMajor depressive disorderFemalebusinessNeurocognitive030217 neurology & neurosurgeryClinical psychology
researchProduct

A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression

2016

Abstract Background Recently there is increasing recognition of cognitive dysfunction as a core feature of Major Depressive Disorder (MDD). The goal of the current meta-analysis was to review and examine in detail the specific features of cognitive dysfunction in Melancholic (MEL) versus Non-Melancholic (NMEL) MDD. Methods An electronic literature search was performed to find studies comparing cognitive performance in MEL versus NMEL. A meta-analysis of broad cognitive domains ( processing speed , reasoning/problem solving , verbal learning , visual learning , attention/working memory ) was conducted on all included studies (n=9). Sensitivity and meta-regression analyses were also conducted…

AdultMaleCognitiveSettore MED/25 - PSCHIATRIACognitive; Depressive disorder; Major depression; Melancholic; NeuropsychologyNeuropsychological TestsVerbal learning03 medical and health sciences0302 clinical medicineMajor depression Depressive disorder Melancholic Cognitive NeuropsychologyNeuropsychologymedicineHumansMajor depressionCognitive; Depressive disorder; Major depression; Melancholic; Neuropsychology; Psychiatry and Mental Health; Clinical PsychologyEffects of sleep deprivation on cognitive performanceDepressive Disorder MajorMelancholicWorking memoryDepressive disorderNeuropsychologyCognitionMiddle Agedmedicine.diseaseExecutive functions030227 psychiatryPsychiatry and Mental healthClinical PsychologyMajor depressive disorderFemalePsychologyCognition DisordersVisual learning030217 neurology & neurosurgeryClinical psychology
researchProduct

Real-world evidence from a European cohort study of patients with treatment resistant depression : Baseline patient characteristics

2021

Journal of affective disorders 283, 115-122 (2021). doi:10.1016/j.jad.2020.11.124

AdultMaleDisease burden; Health-related quality of life; Major depressive disorder; Observational study; Patient-reported outcomes; Socio-economic status; Adult; Cohort Studies; Europe; Female; Humans; Male; Middle Aged; Quality of Life; Depressive Disorder Major; Depressive Disorder Treatment-Resistantmedicine.medical_specialtyHealth-related quality of lifeSocio-economic statusMajor depressive disorderCohort Studies03 medical and health sciencesDepressive Disorder Treatment-Resistant0302 clinical medicineQuality of lifeObservational studyInternal medicinemedicineHumansMedical historyDepression (differential diagnoses)Disease burdenDepressive DisorderDepressive Disorder MajorPatient-reported outcomesDisease burden Health-related quality of life Major depressive disorder Observational study Patient-reported outcomes Socio-economic statusbusiness.industryTreatment-ResistantMajorDisease burdenMiddle Agedmedicine.disease030227 psychiatry3. Good healthEuropePsychiatry and Mental healthClinical PsychologyPresenteeismQuality of LifeMajor depressive disorderFemalebusinessTreatment-resistant depression030217 neurology & neurosurgeryCohort study
researchProduct

A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care

2018

Abstract Background The Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief self-report consisting of a 2-item depression scale (PHQ-2) and a 2-item anxiety scale (GAD-2). The aim of the present study is to determine the psychometric properties of a computerized version of the PHQ-4 used to detect emotional disorders (anxiety and depression) in the primary care setting. Method A total of 1052 patients with suspected anxiety, depression, or somatic symptoms were recruited from 28 primary care centres participating in the PsicAP trial and completed the full version of the computerized PHQ. In addition, 178 of these patients also underwent in clinical interviews as a gold standard. Result…

AdultMaleGeneralized anxiety disorderPsychometricsendocrine system diseasesDepression scalePrimary careAnxietyPatient Health QuestionnaireSensitivity and Specificitybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemedicineCriterion validityHumansScreening tool030212 general & internal medicinePrimary Health CareDepressionbusiness.industryReproducibility of ResultsMiddle Agedmedicine.diseasePatient Health QuestionnairePsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMajor depressive disorderAnxietyFemaleSelf Reportmedicine.symptomFactor Analysis Statisticalbusiness030217 neurology & neurosurgeryClinical psychologyJournal of Affective Disorders
researchProduct

Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology

1985

Abstract Weekly dexamethasone suppression tests (DST) were performed in 19 hospitalized patients with major depressive disorder, endogenous subtype, and who had an abnormal DST at admission. Depression scores (Hamilton Rating Scale) and weight changes were collected by investigators who were blind to the test results. Major findings were: (1) the DST gradually normalized 3–4 weeks prior to full resolution of clinical symptomatology; (2) weight loss was an important patient variable which may have contributed to false positive DST results; however, the positive correlation between changes in DST results and changes in depression scores in all our patients with or without weight loss suggests…

AdultMaleHypothalamo-Hypophyseal Systemmedicine.medical_specialtyBipolar DisorderHydrocortisonePsychometricsEndocrinology Diabetes and MetabolismPituitary-Adrenal SystemDexamethasoneEndocrinologyRating scaleWeight lossInternal medicinemedicineHumansPsychiatryBiological PsychiatryDexamethasoneDepression (differential diagnoses)AgedDepressive DisorderPsychopathologyEndocrine and Autonomic SystemsBody WeightWeight changeMiddle Agedmedicine.diseasePsychiatry and Mental healthMajor depressive disorderFemalemedicine.symptomPsychologyFollow-Up StudiesPsychopathologymedicine.drugPsychoneuroendocrinology
researchProduct

Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated …

2015

Abstract Background Animals show seasonal changes in the endocrine and immune system in response to winter stressors. Even though increased inflammation has been implicated in the pathophysiology of depression, whether immune disorder is a key mediator in seasonal affective depression (SAD) is unknown. Here, we hypothesized that short photoperiods in winter may induce inflammatory response, which contributes to SAD, and that light treatments should normalize immune function and improve depressive symptoms. Methods Twenty patients with a diagnosis of SAD, and a score on the HAM-29 of 20 or higher were recruited for this study. Twenty-one healthy subjects with no personal and family history o…

AdultMaleLight therapymedicine.medical_specialtymedicine.medical_treatmentLymphocyteLymphocyte proliferationProinflammatory cytokineInterferon-gammaInternal medicinemedicineAnimalsHumansLymphocytesInflammationAnalysis of VarianceTumor Necrosis Factor-alphaSeasonal Affective DisorderPhototherapymedicine.diseasePsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureCytokineEndocrinologyImmunologyCytokinesMajor depressive disorderFemaleImmune disorderPsychologyHypothalamic–pituitary–adrenal axisInterleukin-1Journal of Affective Disorders
researchProduct

Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.

2013

Abstract Background Dysfunctions of serotonergic neurotransmission are supposed to be involved in the pathogenesis of psychiatric disorders such as major depressive disorder (MDD). The concentration of serotonin (5-hydroxytryptamine, 5-HT) in the synaptic cleft is essentially regulated by the 5-HT transporter (5-HTT). A length polymorphism repeat in the 5-HTT promoter region, termed 5-HTTLPR, has been commonly investigated for an association with psychiatric disorders. Methods Genotyping of the 5-HTTLPR is time-consuming and technically challenging. Recently, a two-SNP haplotype was identified that tags the 5-HTTLPR at r 2 =0.775. This allows extraction of 5-HTTLPR genotype information from…

AdultMaleLinkage disequilibriumSynaptic cleftGenotypeSingle-nucleotide polymorphismGenome-wide association studyPolymorphism Single NucleotideGermanygenetics [Haplotypes]mental disordersGenotypegenetics [Serotonin Plasma Membrane Transport Proteins]medicineHumansGenetic Predisposition to Diseaseddc:610GeneticsSerotonin Plasma Membrane Transport ProteinsDepressive Disorder MajorSLC6A4 protein humanHaplotypegenetics [Depressive Disorder Major]Middle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyHaplotypes5-HTTLPRCase-Control Studiesgenetics [Polymorphism Single Nucleotide]Major depressive disorderFemalePsychologyClinical psychologyGenome-Wide Association StudyJournal of affective disorders
researchProduct

The long and complex road in the search for treatment for mental disorders: An analysis of the process in five groups of patients

2016

Seeking treatment for mental-health problems is a complex process, with different underlying motives in each stage. However, the entire process and these motives have hardly been investigated. This study aims to analyze the different stages of the help-seeking process and their underlying motives in five groups of patients with different mental disorders. In all, 156 patients seeking treatment in outpatient mental health clinics were individually interviewed: 71 had Obsessive-Compulsive Disorder (OCD), 21 had Agoraphobia (AGO), 18 had Major Depressive Disorder (MDD), 20 had Anorexia Nervosa (AN), and 22 had Cocaine Dependence (COC). The AGO and MDD patients delayed significantly less time i…

AdultMaleObsessive-Compulsive Disordermedicine.medical_specialtyAnorexia NervosaSocial stigmaSocial StigmaPoison controlSuicide preventionTime-to-TreatmentCocaine dependenceCocaine-Related Disorders03 medical and health sciencesHelp-Seeking Behavior0302 clinical medicinemental disordersInjury preventionmedicineHumansPsychiatryAgoraphobiaBiological PsychiatryDepressive Disorder Majorbusiness.industryMental DisordersMiddle Agedmedicine.diseaseMental health030227 psychiatryPsychiatry and Mental healthMajor depressive disorderFemalebusinessAttitude to Health030217 neurology & neurosurgeryAgoraphobiaClinical psychologyPsychiatry Research
researchProduct

Comorbidity, age of onset and suicidality in obsessive–compulsive disorder (OCD): An international collaboration

2017

Made available in DSpace on 2018-12-11T17:11:30Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-07-01 Objectives To collate data from multiple obsessive–compulsive disorder (OCD) treatment centers across seven countries and five continents, and to report findings in relation to OCD comorbidity, age of onset of OCD and comorbid disorders, and suicidality, in a large clinical and ethnically diverse sample, with the aim of investigating cultural variation and the utility of the psychiatric diagnostic classification of obsessive–compulsive and related disorders. Methods Researchers in the field of OCD were invited to contribute summary statistics on current and lifetime psychiatric comor…

AdultMaleObsessive-Compulsive Disordermedicine.medical_specialtyInternationalityGeneralized anxiety disorderlcsh:RC435-571IndiaSuicide AttemptedComorbiditybehavioral disciplines and activitiesSuicidal IdeationSpecific phobiaSouth AfricaYoung Adult03 medical and health sciences0302 clinical medicineJapanlcsh:Psychiatrymental disordersmedicineHumansAge of OnsetPsychiatryObsessive-compulsive disorder (OCD)Suicidal ideationMental DisordersAustraliaMiddle Agedmedicine.diseaseComorbidityhumanities030227 psychiatryCOMORBIDADESuicidePsychiatry and Mental healthClinical PsychologyItalySpainBody dysmorphic disorderMajor depressive disorderAnxietyFemalemedicine.symptomPsychologyBrazil030217 neurology & neurosurgeryClinical psychology
researchProduct

Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years

2020

Background: There is evidence that symptomatology in patients with major depressive disorder (MDD) changes with age. However, studies comparing depressive symptomatology between different age groups during antidepressant therapy are rare. We compared demographic and clinical characteristics in depressed patients of different age groups at baseline and during treatment. Methods: 889 MDD inpatients were divided into four age groups (18–29, 30–39, 40–49, 50–65 yrs.). Demographic and clinical characteristics including depressive symptomatology (assessed by the Inventory of Depressive Symptoms) were assessed at baseline and weekly during treatment. Results: At baseline, young patients (18–29 yea…

AdultMalePediatricsmedicine.medical_specialtyAdolescentlcsh:RC435-571IrritabilityDepressive symptomatology03 medical and health sciencesYoung Adult0302 clinical medicinelcsh:PsychiatrymedicineHumansIn patientDepression (differential diagnoses)AgedDepressive Disorder Majorbusiness.industryDepressionAge FactorsMiddle Agedmedicine.diseasePersonality disordersAntidepressive AgentsIrritable MoodSelf Concept030227 psychiatrySubstance abusePsychiatry and Mental healthClinical PsychologyTreatment OutcomeAntidepressantMajor depressive disorderFemalemedicine.symptombusiness030217 neurology & neurosurgeryComprehensive Psychiatry
researchProduct